Quantcast
Channel: Bioethics.net » Jennifer Miller
Browsing all 13 articles
Browse latest View live

Problem with generic meds: Changes in color, shape may lead to interruptions...

[HarvardScience By: Jessica Maki]  Generic medications currently account for more than 70 percent of prescriptions dispensed. However, although generic drugs are clinically bioequivalent to the...

View Article



NOVARTIS CEO: Big Pharma Has To Move Beyond Just ‘Selling The Pill’

 [Business Insider, Max Nison] Swiss drugmaker Novartis recently lost patent protection on its best selling product, Diovan.  They don’t have anything coming soon which looks like it could replace it....

View Article

Entering the age of the $1 million medicine

  (Reuters, Ben Hirschler)  The Western world’s first drug to fix faulty genes promises to transform the lives of patients with an ultra-rare disease that clogs their blood with fat. The only snag is...

View Article

Bill proposed in Oregon would make cigarettes prescription-only drugs

 [KPTV] If you’re a regular smoker, you may want to keep an eye on a new bill in the Oregon Legislature.  Rep. Mitch Greenlick, from Portland, is sponsoring a bill that makes cigarettes a Schedule III...

View Article

CRO with a scandal-plagued past shuts down, leaving patients stranded

[FierceBiotech | By John Carroll] PRACS Institute, the CRO that attempted to rise Phoenix-like from the ashes  of scandal-plagued Cetero Research,  has reportedly slammed its doors shut, laying off...

View Article


Sugar industry’s secret documents echo tobacco tactics

Sugar Association’s intent to use science to defeat critics uncovered by dentist [CBC News] When Cristin Couzens went on the hunt for evidence that Big Sugar had manipulated public opinion, she had no...

View Article

Diagnosis: Human

[Ted Gup, NYTimes] THE news that 11 percent of school-age children now receive a diagnosis of attention deficit hyperactivity disorder — some 6.4 million — gave me a chill. My son David was one of...

View Article

Orphan Drug Prices Under Siege in Austerity-Minded Europe

“They’ve started looking at how much money…these companies are making… If you make more than a billion dollars out of a product…somebody’s going to wake up and say… you’ve recouped your R&D…you’ve...

View Article


The Cost of Living: New drugs could extend cancer patients’ lives—by days. At...

[NYMag] On August 3, 2012, the Food and Drug Administration approved a new cancer drug called Zaltrap as a safe and effective treatment for patients with advanced colon cancer. The approval was based...

View Article


The risks of risk aversion in drug regulation

[Nature, Abstract] Drugs are approved by regulatory agencies on the basis of their assessment of whether the available evidence indicates that the benefits of the drug outweigh its risks. In recent...

View Article

How a Clinical Trial Registry Became a Symbol of Misinformation

Here is an article that I wrote for the Hastings Center Report describing the problem of missing and misleading information about our medicines and what to do about it.  Abstract.  In 1971, President...

View Article

Bioethics International 2013-11-20 15:25:48

[The Chronicle of Higher Education] Just days after federal prosecutors concluded one of the nation’s largest fraud settlements involving a single drug, at least some university researchers are...

View Article

Bioethics International 2013-11-21 05:26:19

[FiercePharma] Google made major waves two months ago when it landed former Genentech CEO Art Levinson to run its still-murky biotech offshoot, Calico. Now the biotech elder statesman is reuniting with...

View Article

Browsing all 13 articles
Browse latest View live




Latest Images